Sinomenine Inhibits TOPK To Ameliorate Psoriasiform Dermatitis

Area of Science:

• Dermatology
• Pharmacology
• Molecular Biology

Background:

• Psoriasis is a chronic inflammatory skin condition.
• Sinomenine, an alkaloid from Sinomenium acutum, shows anti-inflammatory properties.
• The precise mechanism of sinomenine in psoriasis is not fully understood.

Purpose of the Study:

• To investigate the molecular mechanism and therapeutic targets of sinomenine in psoriasis.
• To determine if sinomenine affects T-LAK cell-originated protein kinase (TOPK) activity.
• To evaluate the efficacy of sinomenine in ameliorating psoriatic phenotypes.

Main Methods:

• In vitro assays to assess sinomenine's binding and inhibition of TOPK activity.
• In vivo and ex vivo experiments to study TOPK activation.
• Assessment of sinomenine's effect on psoriatic phenotypes in vitro and in vivo models.

Main Results:

• Sinomenine directly binds and inhibits TOPK activity in vitro.
• Sinomenine suppresses TOPK activation in both ex vivo and in vivo settings.
• Sinomenine treatment significantly ameliorates psoriatic skin inflammation and related phenotypes.

Conclusions:

• T-LAK cell-originated protein kinase (TOPK) is identified as a direct molecular target of sinomenine.
• Sinomenine demonstrates therapeutic potential for psoriasis by inhibiting TOPK.
• This research offers new insights for clinical strategies in managing psoriatic skin inflammation.